type 2 diabetes Clinical Trials and Research
Also known as: adult-onset diabetes, non-insulin-dependent diabetes mellitus, dm2, insulin resistance diabetes, sugar diabetes · ICD-10: E11
Type 2 diabetes is a chronic condition where the body struggles to use insulin effectively, causing high blood sugar. Clinical trial research focuses on developing new treatments, improving blood sugar control, and preventing complications. Find a Trial helps patients search active studies for type 2 diabetes.
Search type 2 diabetes trials →
Common questions about type 2 diabetes clinical trials
Who can participate in type 2 diabetes clinical trials?
Eligibility criteria vary by study but often include age, diagnosis confirmation, and specific health markers. Researchers ensure participant safety and study relevance. Information on specific criteria is detailed on ClinicalTrials.gov, where each study lists its requirements.
What are the different phases of clinical trials for type 2 diabetes?
Clinical trials typically progress through phases 1 to 4. Early phases assess safety and dosage, while later phases evaluate effectiveness and compare new treatments to existing ones. This systematic approach helps ensure new therapies are safe and beneficial, as detailed on ClinicalTrials.gov.
Do type 2 diabetes clinical trials cost money to participate?
Generally, participants do not pay to join a clinical trial; often, study-related medical care and medications are provided at no cost. Some trials may even offer compensation for time and travel. Details are always outlined in the informed consent process before participation.
What are current research directions for type 2 diabetes?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, explores novel drug targets, weight management strategies, and technologies for continuous glucose monitoring. Studies also investigate ways to prevent complications like kidney disease and neuropathy, aiming for better long-term outcomes.
What types of interventions are studied in type 2 diabetes trials?
Interventions include new medications, lifestyle modifications like diet and exercise programs, and medical devices such as insulin pumps or glucose monitors. Some trials also explore surgical options or combination therapies. These diverse approaches aim to improve blood sugar control and overall health.
Are there specific biomarkers important in type 2 diabetes research?
Yes, key biomarkers include HbA1c, fasting glucose, C-peptide, and insulin resistance markers. Researchers also study genetic markers and inflammatory indicators to understand disease progression and treatment response. These help tailor interventions and predict outcomes, according to NIH RePORTER.
What are common reasons someone might be excluded from a type 2 diabetes trial?
Common exclusion criteria might include uncontrolled co-existing conditions, severe complications, recent cardiovascular events, or certain medications that could interfere with the study drug. Pregnancy or breastfeeding are also frequent exclusions. These criteria protect participants and ensure study integrity.
Are clinical trials exploring type 2 diabetes remission?
Yes, a significant area of research focuses on achieving and maintaining type 2 diabetes remission through intensive lifestyle interventions, specific medications, or bariatric surgery. Studies aim to understand who can achieve remission and how to sustain it, as reported on ClinicalTrials.gov.
How to find a type 2 diabetes trial that fits you
- Describe your type 2 diabetes situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all type 2 diabetes trials →